From COVID to mpox to polio: Our 9 most-read 'viral' stories in 2022
It was a big year for viruses, which simply refused to be ignored. And unlike the previous two years, COVID had to share the spotlight.
HIV
This MacArthur 'genius' grantee says she isn't a drug price rebel but she kind of is
Health justice lawyer Priti Krishtel doesn't believe your ability to heal should depend on your ability to pay. Her mission is to reform the patent system that drug companies use to block competition.
So you haven't caught COVID yet. Does that mean you're a superdodger?
A new study suggests that. yes, there are superdodgers. But explaining why they've been able to avoid the virus is a bit complicated.
The top White House monkeypox doc takes stock of the outbreak — and what's next
Dr. Demetre Daskalakis is steering the U.S. monkeypox response. A month into the job, he sees signs of success, but there's still more to be done.
A nasty disease is even nastier for patients with HIV. Now there's encouraging news
It's called visceral leishmaniasis. It's spread by sandflies and fatal if left untreated. Fortunately, a new drug regimen holds promise.
A drug for HIV appears to reverse a type of memory loss in mice
In mice, the HIV drug maraviroc restored a system that links new memories that are made around the same time. The finding could help treat memory problems in people.
California debates opening supervised sites for people to use drugs
Advocates of the proposal say it would prevent overdoses, slow the spread of HIV and inspire drug users to seek help, while proponents say safe injection sites would create an "open drug scene."
Despite effective treatments, HIV drags on. Experts warn COVID may face the same fate
HIV remains a problem in the U.S. because people don't use life-saving prevention and treatments. COVID is heading down the same path. Here are insights from people fighting on the frontlines of HIV.
Discovery of HIV variant shows virus can evolve to be more severe — and contagious
Findings from a new study help answer questions about why some people get more severe and transmissible HIV than others — and serve as a reminder that viruses don't always weaken over time.
A new injection to prevent HIV, rather than pills, is a game-changer, scientists say
The Food and Drug Administration this week approved an injectable drug that helps prevent the spread of HIV. It only has to be taken once every eight weeks, compared to a daily oral pill.